Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO Sells 90,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John E. Kao sold 90,000 shares of the stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $15.27, for a total transaction of $1,374,300.00. Following the completion of the transaction, the chief executive officer now directly owns 1,823,100 shares of the company's stock, valued at $27,838,737. This trade represents a 4.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Alignment Healthcare Trading Down 0.9%

ALHC stock traded down $0.14 during trading on Friday, hitting $14.94. The company had a trading volume of 1,581,551 shares, compared to its average volume of 2,049,401. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a 50-day moving average price of $16.37 and a 200-day moving average price of $14.92. Alignment Healthcare, Inc. has a 12 month low of $7.05 and a 12 month high of $21.06. The stock has a market cap of $2.96 billion, a price-to-earnings ratio of -19.40 and a beta of 1.22.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The firm had revenue of $926.93 million during the quarter, compared to analysts' expectations of $889.83 million. During the same quarter in the previous year, the company posted ($0.25) EPS. Alignment Healthcare's revenue was up 47.5% on a year-over-year basis. As a group, analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on ALHC. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Bank of America lifted their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a research note on Tuesday, March 4th. Barclays lifted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a research note on Friday, February 28th. Robert W. Baird lifted their target price on shares of Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. Finally, UBS Group lifted their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $17.17.

Institutional Trading of Alignment Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. US Bancorp DE raised its position in shares of Alignment Healthcare by 6,544.2% during the 4th quarter. US Bancorp DE now owns 98,932 shares of the company's stock valued at $1,113,000 after acquiring an additional 97,443 shares during the last quarter. Barclays PLC raised its position in shares of Alignment Healthcare by 144.1% during the 3rd quarter. Barclays PLC now owns 193,446 shares of the company's stock valued at $2,287,000 after acquiring an additional 114,191 shares during the last quarter. Northern Trust Corp raised its position in shares of Alignment Healthcare by 8.6% during the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock valued at $10,226,000 after acquiring an additional 72,063 shares during the last quarter. Franklin Resources Inc. bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at $732,000. Finally, Proficio Capital Partners LLC bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at $184,000. Institutional investors own 86.19% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.